Risk-Based Quality Management banner

Clinical researchers and sponsors are embracing risk-based approaches to quality management and monitoring of clinical studies, but the pathway for implementation can vary depending upon company size, maturity, and culture of innovation. Companies utilizing remote and centralized monitoring strategies are ahead of the curve when study conditions change quickly, particularly when quality is a foundational element throughout the study lifecycle. However, challenges can arise, such as quality oversight of data, data reliability and validation, organizational change management, and regulatory developments. The conference will look at how quality is baked into each element of clinical research, how risk-based approaches are executed by industry leaders and innovators, and how risk-based approaches are received by regulators.






For more details on the conference, please contact:

Iris Goldman
Conference Producer
Phone: (+1) 781-247-1814
Email: igoldman@healthtech.com

 

For sponsorship information, please contact:

 

Companies A-E:

Ilana Quigley

Director, Sales

Phone: (+1) 781-972-5457

Email: iquigley@healthtech.com

 

Companies F-J:

Katelin Fitzgerald
Sr. Manager, Business Development
Phone: (+1) 781-247-1824
Email: kfitzgerald@cambridgeinnovationinstitute.com

Companies K-T:
Jon Stroup
Sr. Manager, Business Development
Phone: (+1) 781-972-5483Email: jons@healthtech.com

Companies U-Z:
Patty Rose
Senior Director, Sales
Phone: (+1) 781-1349
Email: prose@healthtech.com

 

For media and association partnerships, please contact:

Rich Handy

Senior Director, Marketing

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-5456

Email: rhandy@healthtech.com